Induction of an EMT-like transformation and MET in vitro

Journal of Translational Medicine

Shusen Zheng²  Lin Zhou²  Fengqiang Xiao²  Yu Gu¹  Penghong Song²  Kanjie Chen²  Haijun Guo²  Haiyang Xie²  Chunyang Xing²  Zhiyuan Xu²  Wu Zhang²  Songming Ding² 

[1] Key Laboratory of Combined Multi-organ Transplantation, Ministry of Public Health; Key Laboratory of Organ Trans-plantation, Hangzhou, Zhejiang, China;Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, P.R. China

关键词: Conditioned medium culture;    Co-culture;    MET;    EMT;    Tumor microenvironment;   

Others  :  827262
DOI  :  10.1186/1479-5876-11-164

 received in 2012-11-21, accepted in 2013-06-27,  发布年份 2013

【 摘 要 】

Background

The epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) play pivotal roles in metastasis of epithelial cancers. The distinction between them has shed new light on the molecular mechanisms of tumor metastasis. Recently, tumor microenvironment (TM) has been identified as one of the most potent inducers of EMT and MET. TM is characterized by its complexity and flexibility. The purpose of this study was to ascertain the exact effect of each distinct TM component on the evolution hepatocellular carcinoma (HCC) metastasis.

Methods

Two different cell culture models were used. The HCC cell line Bel-7402 was co-cultured with the normal liver cell line HL-7702 or with the retinal vascular endothelial cell line RF/6A in double-layer six-well plates, imitating the direct interaction between tumor-host cells and tumor cells. Bel-7402 was also cultured in the conditioned medium (CM) of the human lung fibroblast cell line MRC-5, HL-7702 or RF/6A, imitating an indirect interaction. Integrin β1, β3, β4, β7, laminin β3, E-cadherin and Snail levels were measured by quantitative RT-PCR in tumor sepecimens from 42 resected HCC.

Results

We found that Bel-7402 cells co-cultured with HL-7702 or RF/6A cells were induced to undergo MET. The expression of E-cadherin, α-catenin and β-catenin was up-regulated, accompanied with a strengthened E-cadherin/catenin complex on the membrane of co-cultured Bel-7402 cells. Consequently, the invasion and migration ability of cells was declined. Conversely, Bel-7402 cells cultured in conditioned medium from MRC-5 cells underwent an EMT-like transformation as the cells became elongated with increased invasion and migration ability. Furthermore, we demonstrated that HL-7702 cells could generally inhibit the tumorigenicity and viability of Bel-7402 cells. We also found that integrin β1 expression was negatively associated with capsular formation, and that integrin β4 expression was negatively associated with CK19 expression.

Conclusion

Our findings highlight the strong influences exerted by TM on tumor progression through EMT and MET by impacting the expression of adhesion molecules, including the E-cadherin/catenin complex, laminins and integrins.

【 授权许可】

   
2013 Ding et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Lorusso G, Rüegg C: The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 2008, 130:1091-1103.
• [2]Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nat Rev Cancer 2008, 9:239-252.
• [3]Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow? Lancet 2001, 357:539-545.
• [4]Wei WZ, Fulton A, Winkelhake J, Heppner G: Correlation of Natural Killer Activity with Tumorigenesis of a Preneoplastic Mouse Mammary Lesion. Cancer Res 1989, 49:2709-2715.
• [5]Coussens LM, Raymond WW, Bergers G, Laig-Webster M, Behrendtsen O, Werb Z, Caughey GH, Hanahan D: Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 1999, 13:1382-1397.
• [6]Vincent-Salomon A, Thiery JP: Host microenvironment in breast cancer development Epithelial–mesenchymal transition in breast cancer development. Breast Cancer Res 2003, 5:101-106. BioMed Central Full Text
• [7]Jou J, Diehl AM: Epithelial-mesenchymal transitions and hepatocarcinogenesis. J Clin Invest 2010, 120:1031-1034.
• [8]Yang J, Mani SA, Weinberg RA: Exploring a New Twist on Tumor Metastasis. Cancer Res 2006, 66:4549-4552.
• [9]Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y, Goodall GJ: The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008, 10:593-601.
• [10]Katoh M: Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 2005, 27:1677-1683.
• [11]Bates RC, Mercurio AM: The Epithelial-Mesenchymal Transition (EMT) and Colorectal Cancer Progression. Cancer Biol Ther 2005, 4:365-370.
• [12]Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial–mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 2006, 172:973-981.
• [13]Thiery JP: Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2002, 2:442-454.
• [14]Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED, Thompson EW: Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007, 213:374-383.
• [15]Spaderna S, Schmalhofer O, Hlubek F, Jung A, Kirchner T, Brabletz T: Epithelial-mesenchymal and mesenchymal-epithelial transitions during cancer progression. Verh Dtsch Ges Pathol 2007, 91:21-28.
• [16]Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED: Mesenchymal-to-Epithelial Transition Facilitates Bladder Cancer Metastasis: Role of Fibroblast Growth Factor Receptor-2. Cancer Res 2006, 66:11271-11278.
• [17]Fitzgerald MP, Gourronc F, Teoh ML, Provenzano MJ, Case AJ, Martin JA, Domann FE: Human Chondrosarcoma Cells Acquire an Epithelial-Like Gene Expression Pattern via an Epigenetic Switch: Evidence for Mesenchymal-Epithelial Transition During Sarcomagenesis. Sarcoma 2011, 2011:598218.
• [18]Peter ME: Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852.
• [19]Naoko T, Warren RQ, Percy Ivy S: Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res 2011, 13(3):211-222. BioMed Central Full Text
• [20]Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S: Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005, 129:1375-1383.
• [21]Gupta SK, Oommen S, Aubry MC, Williams BP, Vlahakis NE: Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene 2013, 32(2):141-150.
• [22]Fidler IJ: Critical determinants of metastasis. Semin Cancer Biol 2002, 12:89-96.
• [23]Brabletz T, Hlubek F, Spaderna S, Schmalhofer O, Hiendlmeyer E, Jung A, Kirchner T: Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and beta-Catenin. Cells Tissues Organs 2005, 179:56-65.
• [24]Lundgren K, Nordenskjöld B, Landberg G: Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer. Br J Cancer 2009, 101:1769-1781.
• [25]Wang Z, Zhao Y, Smith E, Goodall GJ, Drew PA, Brabletz T, Yang C: Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci 2011, 121(1):110-122.
• [26]Thiery J: Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003, 15:740-746.
• [27]Scheel C, Onder T, Karnoub A, Weinberg R: Adaptation versus selection: the origins of metastatic behavior. Cancer Res 2007, 67:11476-11479.
• [28]Huber M, Kraut N, Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005, 17:548-558.
• [29]Tao YS, Ma XY, Chai DM, Ma L, Feng ZZ, Cheng ZN, Lai MD: Overexpression of MMP-1 and VEGF-C is Associated with a Less Favorable Prognosis in Esophageal Squamous Cell Carcinoma. Onkologie 2012, 35:651-656.
• [30]Ning BF, Ding J, Yin C, Zhong W, Wu K, Zeng X, Yang W, Chen YX, Zhang JP, Zhang X, Wang HY, Xie WF: Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. Cancer Res 2010, 70:7640-7651.
• [31]Zhao P, Zhang W, Wang SJ, Yu XL, Tang J, Huang W, Li Y, Cui HY, Guo YS, Tavernier J, Zhang SH, Jiang JL, Chen ZN: HAb18G/CD147 promotes cell motility by regulating annexin II-activated RhoA and Rac1 signaling pathways in hepatocellular carcinoma cells. Hepatolog 2011, 54:2012-2024.
• [32]Li SH, Fu J, Watkins DN, Srivastava RK, Shankar S: Sulforaphane regulates self-renewal of pancreatic cancer stem cells through the modulation of Sonic hedgehog-GLI pathway. Mol Cell Biochem 2012, 373:217-227.
• [33]Parr C, Jiang WG: Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells. Int J Oncol 2001, 19:857-863.
• [34]Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008, 133:704-715.
• [35]Scanlon CS, Van Tubergen EA, Inglehart RC, D’Silva NJ: Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res 2013, 92(2):114-121.
• [36]Santos PB, Zanetti JS, Silva AR, Beltrão EIC: Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study. Diagn Pathol 2012, 7:104. BioMed Central Full Text
• [37]Dingemans AM, van den Boogaart V, Vosse BA, van Suylen RJ, Griffioen AW, Thijssen VL: Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer. Mol Cancer 2010, 9(152):1-9.
• [38]Gonzalez MA, Pinder SE, Wencyk PM, Bell JA, Elston CW, Nicholson RI, Robertson JF: An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1- integrins in invasive breast cancer. J Pathol 1999, 187(5):523-529.
• [39]Yao ES, Zhang H, Chen YY, Lee B, Chew K, Moore D, Park C: Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res 2007, 67(2):659-664.
• [40]Yuan RH, Jeng YM, Hu RH, Lai PL, Lee PH, Cheng CC: Role of p53 and β-catenin mutations in conjunction with CK19 expression on early tumor recurrence and prognosis of hepatocellular carcinoma. J Gastrointest Surg 2011, 15(2):321-329.